Navigation Links
Aware, Inc. Reports First Quarter 2013 Financial Results
Date:4/23/2013


Any other trademarks appearing herein are the property of their respective owners.AWARE, INC.CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share data)(unaudited)Three Months Ended
March 31,20132012Revenue:Software licenses$3,808$2,839Software maintenance1,041881Services476693Royalties291491  Total revenue5,6164,904Costs and expenses:Cost of services221356Research and development1,5571,436Selling and marketing1,0951,079General and administrative731985  Total costs and expenses3,6043,856Operating income before patent related income2,0121,048Income from patent arrangement780-Operating income after patent related income2,7921,048Other income-26Interest income8252Income from continuing operations before income taxes2,8741,126Provision for income taxes1,0172Income from continuing operations1,8571,124Loss from discontinued operations, net of income taxes-(6)Net income$1,857$1,118Basic net income per share:Basic net income per share from continuing operations$0.08$0.05Basic net loss per share from discontinued operations0.00(0.00)Basic net income per share$0.08$0.05Diluted net income per share:Diluted net income per share from continuing operations$0.08$0.05Diluted net loss per share from discontinued operations 0.00(0.00)Diluted net income per share$0.08$0.05Weighted-average shares – basic22,51120,724Weighted-average shares - diluted22,56420,928AWARE, INCCONDENSED CONSOLIDATED BALANCE SHEETS(In thousands)(unaudited)March 31,2013December 31,2012 

ASSETSCash and investments$74,570$73,084Accounts receivable, net5,8294,578Property and equipment, net5,8675,904Deferred tax assets1,6101,760Other assets, net568528Total assets$88,444$85,854LIABILITIES AND STOCKHOLDERS' EQUITYTotal current liabilities$3,480$3,639Long-term deferred revenue285319Total stockholders' equity84,67981,896Total liabilities and stockholders' equity$88,444$85,854 


'/>"/>
SOURCE Aware, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. NASDAQ Sets Ex-Dividend Date for Aware, Inc.s Special Cash Dividend of $1.80 Per Share
2. Aware, Inc. Declares Special Cash Dividend of $1.80 Per Share, or Approximately $40 Million in Total
3. Aware, Inc. Reports Third Quarter 2012 Financial Results
4. Aware, Inc. Reports Second Quarter 2012 Financial Results
5. Aware, Inc. Reports First Quarter 2012 Financial Results
6. University of Florida reports 2012 US shark attacks highest since 2000
7. Invading species can extinguish native plants despite recent reports
8. Study reports iron oxide nanoparticles effective for labeling human endothelial cells
9. Cell Transplantation reports islet cell advancement increases impact on transplantation
10. New low carbon TINA reports
11. Texas Biomed reports faster, more economical method for detecting bioterror threats
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/16/2014)... , October 16, 2014 NXT-ID, Inc. ... the "Company"), a biometric authentication company focused on the ... leading edge technologies including Wocket™, the Smart Wallet, at ... Conferenece. FiRe is a leading global conference on the ... Hosted by Mark Anderson , founder and publisher ...
(Date:10/15/2014)... to an unexpected extent. The outbreak does not follow ... shows a new disease dynamic in regions, where it ... German National Academy of Sciences Leopoldina, acatech – the ... of the German Academies of Sciences and Humanities have ... In the statement the academies call for the following ...
(Date:10/14/2014)... prostate cancer tumors scavenge and hoard copper that is ... may be a fatal weakness. , Researchers at ... cancer cells by delivering a trove of copper along ... brimming with the mineral, leaving non-cancer cells healthy. , ... available for other uses, could soon be tested in ...
Breaking Biology News(10 mins):NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5Prostate cancer's penchant for copper may be a fatal flaw 2
... characterise their Zap-It! product, which uses the tiny electric ... itching caused by insect bites - such as those from ... that is based around a similar piezoelectric mechanism to that ... a medical device, currently available to buy in high street ...
... Molecular biologist Ichiro Matsumoto, Ph.D., of the Monell Center, ... Young Investigators in Gustation, awarded annually by the Association ... who is an emerging leader in the field of ... the understanding of the organization, relationships and connectivity of ...
... of the potentially deadly antibiotic-resistant bacterium known as MRSA ... a new study involving two Northern Arizona University researchers., ... for Microbial Genetics and Genomics, and Lance Price, NAU ... Microbiology and Environmental Health at the Translational Genomics Research ...
Cached Biology News:Zapping mosquito bites 2Evolution of staph 'superbug' traced between humans and food animals 2
(Date:10/22/2014)... Shimadzu Scientific Instruments introduces its Open Solution QuantAnalytics(TM) ... management and clinical markets. The software increases the speed ... users to highlight and review results that are of ... to filter results by group or based on a ... need to sift through analytes of no interest. In ...
(Date:10/22/2014)... UAE (PRWEB) October 22, 2014 Grace ... science and healthcare projects, announces the addition of ... DCH to its advisory team. Dr. Siddiqui will provide ... , A graduate of University College Medical ... subsequently degreed in medicine in 2001. With further certification ...
(Date:10/22/2014)... , Oct. 22, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" ... announced next steps for its Oral Amphotericin B ... its in vitro work involving samples ... now plans to complete pre clinical studies and ... Phase 1A clinical trial, utilizing approximately $700,000 of ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
Breaking Biology Technology:Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2Dr. Yousef Siddiqui joins the Grace Century Advisory Team 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4
... ... Intellectual Property, FULLERTON, Calif., Nov. 28 Beckman Coulter,Inc. ... and,automate complex biomedical testing announced today that it has entered,into an ... spin out of Lumigen, Inc., effected prior to Beckman,Coulter,s acquisition of ...
... Cambridge Research &,Instrumentation (CRi) announced today that ... of allowance for their patent application number,10/669,101, for ... patent covers the use of multispectral imaging combined,with ... of,fluorophores in a living mammal. The unmixing of ...
... 1-41 has significant ... and anti-amnesic benefits, GENEVA, Nov. 28 /PRNewswire-FirstCall/ - ... announce promising developments with,ANAVEX 1-41, the company,s lead drug ... 1-41 prevented oxidative stress,which damages and destroys cells and ...
Cached Biology Technology:Beckman Coulter to Acquire Exclusive Rights to Break-Through Technologies 2US Patent and Trademark Office Allows CRi's Patent Application for Spectral Imaging of Deep Tissue 2Anavex advances drug candidate for treatment of Alzheimer's disease 2Anavex advances drug candidate for treatment of Alzheimer's disease 3Anavex advances drug candidate for treatment of Alzheimer's disease 4Anavex advances drug candidate for treatment of Alzheimer's disease 5
...
...
Immunogen: Peptide corresponding to amino acid residues from the N-terminal region of human thyroid hormone receptor, alpha1/alpha2-isotype. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Antibodies were affinity purified using epitopes specific to QKI immobilized on solid support....
Biology Products: